Clinical Trial Update: Enbrel® in Psoriatic Arthritis [Phase 4]

View source ↗

Summary

Phase 4 trial of Enbrel (etanercept) for psoriatic arthritis has completed (sponsor: Amgen).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis
• Psoriatic Arthritis

Drugs mentioned

• ENBREL (etanercept)

Snippet

Sponsor: Amgen | Conditions: Psoriasis | Phase 4 | Status: COMPLETED